Medical Device Connectivity market is driven by
increasing integration of healthcare IT infrastructure

The Medical Device Connectivity market involves technology
and software that enables networking between medical devices in healthcare
facilities and clinical information systems for effective data management.
Medical Device Connectivity allows clinicians to access patient data on vitals
such as blood pressure, temperature, heart rate, and oxygen levels remotely and
in real-time. This assists clinicians in timely diagnosis and treatment.
Additionally, Medical Device Connectivity helps reduce manual documentation
errors and improves workflow efficiency. The global connectivity of medical
devices aids hospitals and healthcare centers in streamlining operations and
improving patient safety.

Global Medical Device Connectivity market is estimated to be
valued at US$ 3.5 Billion in 2023 and is
expected to exhibit a CAGR of 25.8% during
the forecast period (2023-2030).



Key Takeaways

Key players operating in the Medical Device Connectivity are Diabetomics, Inc.,
Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, PerkinElmer Inc.,
Siemens Healthineers AG, DRG INSTRUMENTS GMBH, Metabolomic Diagnostics Ltd.,
Sera Prognostics, MOMM Diagnostics, Miraculins Inc. These players are focusing
on developing advanced connectivity solutions to integrate medical devices with
healthcare IT systems.



The Medical
Device Connectivity Market Growth for integrated healthcare is boosting
the Medical Device Connectivity market. Patients are increasingly relying on
remote and home healthcare options using connected medical devices. This is
driving the need for seamless networking of medical equipment with clinical
databases. Furthermore, the rising prevalence of chronic diseases is also
propelling the demand for Medical Device Connectivity solutions to efficiently
manage high-risk patients.

Get
More Insights on- Medical
Device Connectivity market